Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine

Patent No. EP2608789 (titled "Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine") was filed by H Lundbeck on Aug 22, 2011. The application was issued on Aug 21, 2024.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HEXALJan 11, 2018KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2608789

H LUNDBECK
Application Number
EP11749331A
Filing Date
Aug 22, 2011
Status
Patent Maintained As Amended
Jul 19, 2024
Publication Date
Aug 21, 2024